Skip to main content
Clinical Trials/NCT04609514
NCT04609514CompletedNot Applicable

Early-phase Studies of a Tailored Evidence-Based Smoking Cessation mHealth App for Persons Living With HIV

Duke University1 site in 1 country51 target enrollmentStarted: January 25, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
51
Locations
1
Primary Endpoint
Participant Attrition at Three Months

Study Overview

Brief Summary

The study team will conduct a feasibility, acceptability, and preliminary efficacy trial comparing Learn to Quit-HIV (n=30) to an app based on U.S. Clinical Practice Guidelines only (NCI QuitGuide; n=30) among HIV-positive smokers. Both apps will be integrated with NRT and ongoing HIV clinical care.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • HIV-positive
  • Currently engaged with an HIV care provider
  • Self-report smoking 5 cigarettes or more per day during the past 30 days
  • Age 18 years or older
  • Current interest in quitting smoking
  • Currently own a functioning Android or Apple smartphone

Exclusion Criteria

  • No desire to quit smoking
  • Inability to attend study sessions
  • Inability to provide informed consent
  • Any medical condition or concomitant medication that could compromise subject safety or treatment, as determined by the Principal Investigators and/or Study Physician
  • Presence of contraindications for nicotine patch
  • Previous allergic reaction or hypersensitivity to nicotine patch (lifetime)
  • Current use of nicotine replacement therapy or other smoking cessation treatment (e.g., bupropion, varenicline)
  • Pregnant, planning to become pregnant, nursing, or becoming pregnant during the study
  • Current untreated and unstable diagnosis of alcohol/substance abuse or dependence (eligible if past abuse/dependence and if receiving treatment and stable for >30 days)

Arms & Interventions

Learn to Quit-HIV

Experimental

A smartphone app developed by the research team designed for people with HIV that provides Acceptance and Commitment Therapy skills to address smoking cessation. This app intervention is combined with an 8-week course of nicotine replacement therapy (NRT) patches, along with technical smartphone coaching for the first 4 weeks of the study.

Intervention: Learn to Quit-HIV (Device)

Learn to Quit-HIV

Experimental

A smartphone app developed by the research team designed for people with HIV that provides Acceptance and Commitment Therapy skills to address smoking cessation. This app intervention is combined with an 8-week course of nicotine replacement therapy (NRT) patches, along with technical smartphone coaching for the first 4 weeks of the study.

Intervention: Nicotine patch (Drug)

Learn to Quit-HIV

Experimental

A smartphone app developed by the research team designed for people with HIV that provides Acceptance and Commitment Therapy skills to address smoking cessation. This app intervention is combined with an 8-week course of nicotine replacement therapy (NRT) patches, along with technical smartphone coaching for the first 4 weeks of the study.

Intervention: Smartphone coaching (Behavioral)

QuitGuide

Active Comparator

A smartphone app developed by the National Cancer Institute which uses smoking cessation recommendations contained in the US DHHS (United States Department of Health and Human Services) Clinical Practice Guidelines. This app intervention is combined with an 8-week course of nicotine replacement therapy (NRT) patches, along with technical smartphone coaching for the first 4 weeks of the study.

Intervention: QuitGuide (Behavioral)

QuitGuide

Active Comparator

A smartphone app developed by the National Cancer Institute which uses smoking cessation recommendations contained in the US DHHS (United States Department of Health and Human Services) Clinical Practice Guidelines. This app intervention is combined with an 8-week course of nicotine replacement therapy (NRT) patches, along with technical smartphone coaching for the first 4 weeks of the study.

Intervention: Nicotine patch (Drug)

QuitGuide

Active Comparator

A smartphone app developed by the National Cancer Institute which uses smoking cessation recommendations contained in the US DHHS (United States Department of Health and Human Services) Clinical Practice Guidelines. This app intervention is combined with an 8-week course of nicotine replacement therapy (NRT) patches, along with technical smartphone coaching for the first 4 weeks of the study.

Intervention: Smartphone coaching (Behavioral)

Outcomes

Primary Outcomes

Participant Attrition at Three Months

Time Frame: 3 month

Number of participants lost-to-follow-up at three months.

Frequency of App Use as Measured by Interactions Per Day

Time Frame: 3 months

Average frequency of app use per arm over participants' 3 months of study participation.

App Usability as Measured by the Systems Usability Scale

Time Frame: 1 month or next available time point if participant completed the measure at 3 months.

Average app usability scores as measured by the Systems Usability Scale. The scale has a score range of 0 to 100 with higher scores representing better outcomes.

Participant Attrition at One Month

Time Frame: 1 month

Number of participants lost to follow-up at one month.

Participant Attrition at Two Months

Time Frame: 2 months

Number of participants lost-to-follow-up at two months.

Recruitment as Measured by the Proportion of Goal Participants Consented

Time Frame: 1 year

Number of participants consented divided by goal of consenting 60 participants.

Duration of Daily App Use

Time Frame: 3 months

Average duration of app use per arm over participants' 3 months of study participation

Secondary Outcomes

  • Reduction in Cigarettes Smoked Per Day(3 months)
  • Number of Quit Attempts(3 months)
  • 7-day Point Prevalence Abstinence(3 months)
  • Number of Participants With at Least One Adverse Event Determined to be Related to the Study Interventions(3 months)
  • Overall Adherence to Nicotine Replacement Therapy(baseline to 3 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Learn to Quit-HIV Pilot Study | Clinical Trial